Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against Klebsiella pneumoniae by MALDI-TOF MS

Introduction: Resistance to carbapenems due to the co-production of NDM and ESBL or NDM and KPC is increasing. Therefore, combined therapy with aztreonam (ATM) plus ceftazidime/avibactam (CZA) has been recommended. Then, it is necessary to develop and evaluate fast and simple methods to determine sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilhelm, Camila Mörschbächer, Inamine, Everton, Martins, Andreza Francisco, Barth, Afonso Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295265/
https://www.ncbi.nlm.nih.gov/pubmed/37370382
http://dx.doi.org/10.3390/antibiotics12061063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295265/
https://www.ncbi.nlm.nih.gov/pubmed/37370382
http://dx.doi.org/10.3390/antibiotics12061063

Ejemplares similares